Literature DB >> 17718698

Quality of life in Friedreich ataxia: what clinical, social and demographic factors are important?

C L Wilson1, M C Fahey, L A Corben, V R Collins, A J Churchyard, P J Lamont, M B Delatycki.   

Abstract

The aim of this study was to examine the impact of Friedreich ataxia (FRDA) on quality of life (QOL) using a generic tool to explore factors potentially associated with health status. Sixty-three individuals with genetically confirmed FRDA, self completed the Medical Outcomes Study 36 item Short Form Health Survey Version 2 (SF-36V2) and were assessed using the FRDA Rating Scale. Disease-specific, demographic, and social characteristics were also recorded. SF-36V2 results were compared with Australian population norms. Sample subgroups of disease severity and age at disease onset were reviewed. Physical and mental component summaries were examined in relation to clinical and social characteristics using multiple linear regression. QOL is significantly worse in individuals with FRDA compared with population norms. Those with severe disease did not perceive a lower QOL than those with mild or moderate disease except in their physical functioning. A later age of onset and increased disease severity were negatively associated with physical QOL, whilst, increased disease duration was positively associated with mental QOL. There were limitations associated with the use of SF-36V2 in the FRDA population. Further exploration of health-related QOL and FRDA may benefit from the use of a more appropriate generic tool.

Entities:  

Mesh:

Year:  2007        PMID: 17718698     DOI: 10.1111/j.1468-1331.2007.01881.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  14 in total

Review 1.  Quality of life in rare genetic conditions: a systematic review of the literature.

Authors:  Julie S Cohen; Barbara B Biesecker
Journal:  Am J Med Genet A       Date:  2010-05       Impact factor: 2.802

2.  A novel deletion-insertion mutation identified in exon 3 of FXN in two siblings with a severe Friedreich ataxia phenotype.

Authors:  Marguerite V Evans-Galea; Louise A Corben; Justin Hasell; Charles A Galea; Michael C Fahey; Desirée du Sart; Martin B Delatycki
Journal:  Neurogenetics       Date:  2011-08-10       Impact factor: 2.660

3.  Gait pattern in inherited cerebellar ataxias.

Authors:  Mariano Serrao; Francesco Pierelli; Alberto Ranavolo; Francesco Draicchio; Carmela Conte; Romildo Don; Roberto Di Fabio; Margherita LeRose; Luca Padua; Giorgio Sandrini; Carlo Casali
Journal:  Cerebellum       Date:  2012-03       Impact factor: 3.847

4.  The Working Life of People with Degenerative Cerebellar Ataxia.

Authors:  A Ranavolo; M Serrao; T Varrecchia; C Casali; A Filla; A Roca; A Silvetti; C Marcotulli; B M Rondinone; S Iavicoli; F Draicchio
Journal:  Cerebellum       Date:  2019-10       Impact factor: 3.847

5.  Common data elements for clinical research in Friedreich's ataxia.

Authors:  David R Lynch; Massimo Pandolfo; Jorg B Schulz; Susan Perlman; Martin B Delatycki; R Mark Payne; Robert Shaddy; Kenneth H Fischbeck; Jennifer Farmer; Paul Kantor; Subha V Raman; Lisa Hunegs; Joanne Odenkirchen; Kristy Miller; Petra Kaufmann
Journal:  Mov Disord       Date:  2012-12-12       Impact factor: 10.338

6.  Health-related quality of life and depressive symptoms in Friedreich ataxia.

Authors:  Javier Pérez-Flores; Atteneri Hernández-Torres; Fernando Montón; Antonieta Nieto
Journal:  Qual Life Res       Date:  2019-09-28       Impact factor: 4.147

7.  Exploration of transitional life events in individuals with Friedreich ataxia: implications for genetic counseling.

Authors:  V Brook White; Jennifer R Leib; Jennifer M Farmer; Barbara B Biesecker
Journal:  Behav Brain Funct       Date:  2010-10-27       Impact factor: 3.759

Review 8.  Evaluating the progression of Friedreich ataxia and its treatment.

Authors:  Martin B Delatycki
Journal:  J Neurol       Date:  2009-03       Impact factor: 4.849

Review 9.  Diagnosis and treatment of Friedreich ataxia: a European perspective.

Authors:  Jörg B Schulz; Sylvia Boesch; Katrin Bürk; Alexandra Dürr; Paola Giunti; Caterina Mariotti; Francoise Pousset; Ludger Schöls; Pierre Vankan; Massimo Pandolfo
Journal:  Nat Rev Neurol       Date:  2009-04       Impact factor: 42.937

Review 10.  Standardized Assessment of Hereditary Ataxia Patients in Clinical Studies.

Authors:  Brigitte K Paap; Sandra Roeske; Alexandra Durr; Ludger Schöls; Tetsuo Ashizawa; Sylvia Boesch; Lisa M Bunn; Martin B Delatycki; Paola Giunti; Stéphane Lehéricy; Caterina Mariotti; Jörg Melegh; Massimo Pandolfo; Chantal M E Tallaksen; Dagmar Timmann; Shoji Tsuji; Jörg Bela Schulz; Bart P van de Warrenburg; Thomas Klockgether
Journal:  Mov Disord Clin Pract       Date:  2016-02-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.